Under construction – not a live service
Sign in
Taking people in ItalyPhase 1

Tests cevostamab injections in adults with relapsed or refractory multiple myeloma

Tests cevostamab injected under the skin in adults with myeloma that returned.

Key facts

Who runs it
Genentech Inc.
Where
Bologna and Rozzano, ItalySee the 2 sitesAlso in 2 other countries, 4 sites
Registry title
A study to evaluate the Safety, Pharmacokinetics, and Activity of Subcutaneous Cevostamab (BFCR4350A) in Patients with Relapsed or Refractory Multiple Myeloma (CAMMA 3)
Status
Recruiting
Phase
Phase 1
People taking part
45 people, planned
Started
8 Dec 2021
Expected to end
30 Jun 2028
Type of study
Interventional
Record updated
24 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults whose multiple myeloma has come back or has not responded to earlier treatment.

Age
18 years or older
Sex
Women and men can join.
Disease stage
Multiple myeloma that has relapsed or is refractory (it came back or did not respond to treatment).

Where in Italy

Also in 2 other countries, 4 sites

  • Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere ScientificoBologna, ItalyTaking people
  • Humanitas Mirasole S.p.A.Rozzano, ItalyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Plain-language title
Tests cevostamab injections in adults with relapsed or refractory multiple myelomaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
24 August 2026